Respiratory Research unit, Bispebjerg Hospital

The medical center is at the forefront of respiratory medicine, focusing on innovative treatments for chronic obstructive pulmonary disease (COPD). The center's research is dedicated to understanding and mitigating airway inflammation and enhancing the epithelial immune response to exacerbation triggers.

• Airway Inflammation
• Epithelial Immune Response
• Exacerbation Triggers

Through cutting-edge clinical trials, the center is pioneering the use of tezepelumab to target eosinophilic bronchial mucosal tissue inflammation, offering new hope for patients with COPD.